Cargando…
Methylene blue is not a pure vasoconstrictor drug
Autor principal: | Evora, Paulo Roberto Barbosa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4900347/ https://www.ncbi.nlm.nih.gov/pubmed/27052080 http://dx.doi.org/10.4103/0971-9784.179593 |
Ejemplares similares
-
COVID-19 should be a methylene blue “promoter”
por: Evora, Paulo Roberto B.
Publicado: (2020) -
Methylene blue unresponsive methemoglobinemia
por: Mirakbari, Seyed Mostafa
Publicado: (2014) -
COVID-19 and Methylene Blue
por: Wiwanitkit, Viroj
Publicado: (2021) -
Methylene Blue For Post-Cardioplumonary Bypass Vasoplegic Syndrome
por: Pangasa, Neha, et al.
Publicado: (2017) -
Vasoplegia during radical prostatectomy: Methylene blue to rescue
por: Manish, Tandon, et al.
Publicado: (2023)